Kimberly A Petrillo

Title: Kimberly A. Petrillo: Innovator in Ribonucleoside Research

Introduction

Kimberly A. Petrillo is a notable inventor based in Philadelphia, PA (US). She has made significant contributions to the field of biochemistry, particularly in the development of ribonucleosides. Her work is essential in advancing treatments for viral infections.

Latest Patents

Kimberly holds a patent for a process titled "Process for preparing branched ribonucleosides from 1,2-anhydroribofuranose intermediates." This innovative process allows for the preparation of branched-chain ribonucleosides, which are crucial in the development of inhibitors for HCV polymerase. The compounds produced through this method are useful in treating HCV infections. She has 1 patent to her name.

Career Highlights

Kimberly is currently employed at Merck & Co., Inc., where she continues her research and development efforts. Her work at Merck has positioned her as a key player in the pharmaceutical industry, contributing to advancements in drug development.

Collaborations

Throughout her career, Kimberly has collaborated with esteemed colleagues, including Feng Xu and Matthew M. Bio. These partnerships have enhanced her research and expanded the impact of her innovations.

Conclusion

Kimberly A. Petrillo is a pioneering inventor whose work in ribonucleoside research is making a difference in the treatment of viral infections. Her contributions to the field are invaluable and continue to inspire future innovations.